Evidence map›Paper›PMID 32756570›Full record

ArticlePloS one2020

Long-term variations of arterial stiffness in patients with obesity and obstructive sleep apnea treated with continuous positive airway pressure.

Louis-Marie Galerneau, Sébastien Bailly, Jean-Christian Borel, Ingrid Jullian-Desayes, Marie Joyeux-Faure, Meriem Benmerad, Marisa R Bonsignore, Renaud Tamisier, Jean-Louis Pépin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Hypertension is the crucial link between obstructive sleep apnea and arterial stiffness.Journal of clinical hypertension (Greenwich, Conn.) · 2022
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Louis-Marie GalerneauHP2 Laboratory, INSERM U1042, University Grenoble Alpes, Grenoble, France.ORCID 0000-0002-3725-7331
Sébastien BaillyHP2 Laboratory, INSERM U1042, University Grenoble Alpes, Grenoble, France.
Jean-Christian BorelHP2 Laboratory, INSERM U1042, University Grenoble Alpes, Grenoble, France.
Ingrid Jullian-DesayesHP2 Laboratory, INSERM U1042, University Grenoble Alpes, Grenoble, France.
Marie Joyeux-FaureHP2 Laboratory, INSERM U1042, University Grenoble Alpes, Grenoble, France.
Meriem BenmeradHP2 Laboratory, INSERM U1042, University Grenoble Alpes, Grenoble, France.
Marisa R BonsignoreDivision of Respiratory Medicine, PROMISE Dept, University of Palermo, Palermo, Italy.
Renaud TamisierHP2 Laboratory, INSERM U1042, University Grenoble Alpes, Grenoble, France.
Jean-Louis PépinHP2 Laboratory, INSERM U1042, University Grenoble Alpes, Grenoble, France.
Inserm · FRIstituto di Biomedicina e di Immunologia Molecolare Alberto Monroy · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObstructive sleep apnea (OSA) is associated with cardiovascular co-morbidities and mortality. Arterial stiffness is an independent predictor of cardiovascular risk and mortality, and is influenced by the presence of OSA and related comorbidities. There is a paucity of data regarding long-term evolution of arterial stiffness in CPAP-treated OSA patients. We aimed to prospectively study long term PWV variations and determinants of PWV deterioration.

methodsIn a prospective obese OSA cohort, at time of diagnosis and after several years of follow-up we collected arterial stiffness measured by carotid-femoral pulse wave velocity (PWV), clinical and metabolic parameters, and CPAP adherence. Univariate and multivariate analyses were performed in order to determine contributing factors.

resultsSeventy two OSA patients (men: 52.8%, median age: 55.8 years and median BMI of 38.5 kg/m2) with a prevalence of hypertension: 58.3%, type 2 diabetes: 20.8%, hypercholesterolemia: 33.3%, current or past smoking: 59.7%, were evaluated after a median follow-up of 7.4 [5.8; 8.3] years. Over the period of follow-up, the median increase in PWV was 1.34 [0.10; 2.37] m/s. In multivariate analysis, the increase in PWV was associated with older age (10 extra years was associated with a 5.24 [1.35; 9.12] % increase in PWV) and hypertension (a significant increase in PWV of 8.24 [1.02; 15.57] %). No impact of CPAP adherence on PWV evolution was found.

conclusionPWV progression in CPAP-treated OSA patients is mainly related to pre-existing cardio-metabolic comorbidities and not influenced by CPAP adherence. In this high cardiovascular risk population, it is crucial to associated weight management and exercise with CPAP treatment.

Indexed as

Blood Pressure Monitoring, AmbulatoryCardiovascular DiseasesCohort StudiesContinuous Positive Airway PressureFemaleHumansMaleMiddle AgedObesityPolysomnographyRisk FactorsSleep Apnea, ObstructiveVascular Stiffness

Identifiers

PMID32756570
PMCPMC7406029
OpenAlexW3047261220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.